StockpollyBeta
Get App
Popularity #1,476
ADMA · NASDAQ · Biotechnology

ADMA Biologics (ADMA)

Manufactures plasma-derived immune globulins for primary immune deficiency and hepatitis B exposure.

$9.49
vs last close−0.32 (−3.26%)

  1. Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know

    Zacks Investment Research

  2. Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)

    Newsfile Corp

  3. Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

    Zacks Investment Research

  4. Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know

    Zacks Investment ResearchMarket move

  5. Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?

    Zacks Investment ResearchMarket move

  6. Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA

    Defense World

  7. Can Asceniv Help ADMA Stock Combat IG Market Challenges?

    Zacks Investment Research

  8. ADMA Biologics: The Earnings Reset Still Leaves More Upside

    Seeking Alpha

  9. Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)

    Newsfile Corp

  10. ADMA Biologics, Inc. Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

    GuruFocus

  11. ADMA Biologics, Inc. Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

    PRNewsWire

  12. Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    Newsfile Corp

  13. ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

    GuruFocus

  14. CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

    Business Wire

  15. ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline

    PRNewsWire

  16. ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA

    PRNewsWire

  17. ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

    PRNewsWire

  18. DEADLINE NEXT WEEK: Hagens Berman Advises ADMA Biologics, Inc. Investors to Contact the Firm Before August 10, 2026

    GuruFocus

  19. DEADLINE NEXT WEEK: Hagens Berman Advises ADMA Biologics, Inc. Investors to Contact the Firm Before August 10, 2026

    PRNewsWire

  20. ADMA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

    Newsfile Corp

  21. ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

    GlobeNewsWire

  22. ADMA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm - ADMA

    Newsfile Corp

  23. ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm - ADMA

    Newsfile Corp

  24. ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

    Business Wire